WACC Grey's Pharmaceuticals has a new project that will require funding of $10.2 million. The company has decided to pursue an all-debt scenario. Grey's has made agreements with four lenders for the needed financing These lenders will advance the following amounts at the interest rates shown Lendor Steven Yang Shepherd Bailey 3,845,410 $2,917,575 $2,314,186 $1.122,829 Interest Rate 13% 11% 8% 9% What is the weighted average cost of capital for the $10,200,000 What is the weighted average cost of capital for the $10,200,000